This page is part of the FHIR Specification (v1.6.0: STU 3 Ballot 4). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile Diagnostic Report for Genetics (FHIR Specification Core)).
Gene DNAVariation Status Interpretation BRCA1 Negative BRCA2 185delAG Positive Pathogenic
Method: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc
Issued: 2015-05-26T15:30:10+01:00
FamilyMemeberHistory: Mother
Gene DNAVariation Status BRCA2 185delAG Positive
Method: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.